14 January 2022>: Database Analysis
H2A Histone Family Member Z (H2AFZ) Serves as a Prognostic Biomarker in Lung Adenocarcinoma: Bioinformatic Analysis and Experimental Validation
Zongkuo Li 12AE , Menglong Hu 12A , Jinhuan Qiu 12C , Junkai Feng 12C , Ruizhen Zhang 1C , Huifang Wu 1D , Guiming Hu 1D , Jingli Ren 1G*DOI: 10.12659/MSM.933447
Med Sci Monit 2022; 28:e933447
Table 3 Association between H2AFZ expression and clinicopathological characteristics in patients with LUAD in our cohort.
Characteristics | H2AFZ expression | Total | p Value | |
---|---|---|---|---|
Low (n=220) | High (n=219) | |||
Age | ||||
29 | 51 | 80 | 0.865 | |
≥65 | 10 | 19 | 29 | |
Gender | ||||
Male | 14 | 40 | 54 | |
Female | 25 | 30 | 55 | |
Pathological stage | ||||
I | 25 | 36 | 61 | |
II | 5 | 23 | 28 | |
III | 8 | 6 | 14 | |
IV | 1 | 5 | 6 | |
T classification | ||||
T1 | 23 | 45 | 68 | 0.801 |
T2 | 10 | 18 | 28 | |
T3 | 5 | 5 | 10 | |
T4 | 1 | 2 | 3 | |
N classification | ||||
N0 | 23 | 41 | 64 | 0.679 |
N1 | 4 | 11 | 15 | |
N2 | 12 | 18 | 30 | |
N3 | ||||
Bold values indicate |